H J de Koning

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. ncbi request reprint Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial
    Harry J de Koning
    Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Int J Cancer 97:237-44. 2002
  2. ncbi request reprint Breast cancer screening; cost-effective in practice?
    H J de Koning
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Eur J Radiol 33:32-7. 2000
  3. ncbi request reprint Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands
    J H Groenewoud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:211-8. 2007
  4. ncbi request reprint Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer
    J B Madalinska
    Department of Public Health, Erasmus University, Rotterdam, The Netherlands
    J Clin Oncol 19:1619-28. 2001
  5. ncbi request reprint Short-term effects of population-based screening for prostate cancer on health-related quality of life
    M L Essink-Bot
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 90:925-31. 1998
  6. ncbi request reprint Pathologic features of prostate cancer found at population-based screening with a four-year interval
    R F Hoedemaeker
    Department of Pathology, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 93:1153-8. 2001
  7. doi request reprint Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
    C M van der Aalst
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Lung Cancer 77:51-7. 2012
  8. ncbi request reprint Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment
    J B Madalinska
    Department of Public Health, Erasmus University Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Prostate 46:87-97. 2001
  9. doi request reprint Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?
    H M H J D Schoonen
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Patient Educ Couns 84:265-70. 2011
  10. pmc Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
    E M Wever
    Department of Public Health, Erasmus Medical Center, P O Box 2040, Rotterdam, 3000, CA, The Netherlands
    Br J Cancer 108:1971-7. 2013

Detail Information

Publications58

  1. ncbi request reprint Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial
    Harry J de Koning
    Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Int J Cancer 97:237-44. 2002
    ..The differences between countries seem to reflect both underlying prostate cancer incidence and screening policy. The trials have the power to show definitive results in 2005-2008...
  2. ncbi request reprint Breast cancer screening; cost-effective in practice?
    H J de Koning
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Eur J Radiol 33:32-7. 2000
    ..On a national scale, with hundreds of professional practitioners, it can be expected to be more difficult to attain uniform quality. Continuous quality control, monitoring and evaluation are therefore crucial...
  3. ncbi request reprint Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands
    J H Groenewoud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:211-8. 2007
    ....
  4. ncbi request reprint Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer
    J B Madalinska
    Department of Public Health, Erasmus University, Rotterdam, The Netherlands
    J Clin Oncol 19:1619-28. 2001
    ....
  5. ncbi request reprint Short-term effects of population-based screening for prostate cancer on health-related quality of life
    M L Essink-Bot
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 90:925-31. 1998
    ....
  6. ncbi request reprint Pathologic features of prostate cancer found at population-based screening with a four-year interval
    R F Hoedemaeker
    Department of Pathology, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 93:1153-8. 2001
    ..Our goal was to determine if a longer interval would compromise the detection of curable prostate cancer...
  7. doi request reprint Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
    C M van der Aalst
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Lung Cancer 77:51-7. 2012
    ..Results of the NELSON trial will be roughly applicable to the Dutch and probably other populations that fulfil our selection criteria...
  8. ncbi request reprint Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment
    J B Madalinska
    Department of Public Health, Erasmus University Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Prostate 46:87-97. 2001
    ..The purpose of this study was to evaluate baseline health-related quality of life (HRQOL) in patients with localized prostate cancer before primary treatment (radical prostatectomy or radiotherapy)...
  9. doi request reprint Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?
    H M H J D Schoonen
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Patient Educ Couns 84:265-70. 2011
    ....
  10. pmc Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
    E M Wever
    Department of Public Health, Erasmus Medical Center, P O Box 2040, Rotterdam, 3000, CA, The Netherlands
    Br J Cancer 108:1971-7. 2013
    ..We quantified how the benefits and harms of immediate treatment vary according to the prognostic factors of clinical T-stage, Gleason score, and patient age...
  11. ncbi request reprint Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
    M L Essink-Bot
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, The Netherlands
    BJU Int 92:101-5. 2003
    ..g. the EQ-5D) and linking these descriptions to utility estimates using the standard preference-based algorithm, combining them with the appropriate duration into quality-adjusted life years, and sensitivity analysis...
  12. ncbi request reprint Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition
    M L Essink-Bot
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Breast 15:673-6. 2006
    ..MRI provided the most reassurance of breast cancer being absent in case of a favourable test result. MRI seems to be acceptable as a screening test for women at increased breast cancer risk and is preferred by them over mammography...
  13. pmc To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
    E M Wever
    Department of Public Health, Erasmus Medical Center, PO Box 2040, Rotterdam 3000 CA, The Netherlands
    Br J Cancer 107:778-84. 2012
    ..We estimated benefits and adverse effects of PSA screening for individuals who are deciding whether or not to be screened...
  14. pmc Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
    N T van Ravesteyn
    Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam 3000 CA, The Netherlands
    Br J Cancer 105:1082-8. 2011
    ..In this study, the trial is simulated in order to gain insight into the results of the trial and to predict the effect of different screening intervals on breast cancer mortality...
  15. pmc Interval cancers in the Dutch breast cancer screening programme
    J Fracheboud
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Br J Cancer 81:912-7. 1999
    ..Measures should be considered to improve the detection of small invasive cancers and to reduce false-negative rates, even if this will lead to increasing referral rates...
  16. pmc Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
    E A M Heijnsdijk
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Br J Cancer 101:1833-8. 2009
    ..Overdetection and overtreatment are substantial unfavourable side effects with consequent healthcare costs. In this study the effects of introducing widespread PSA screening is evaluated...
  17. pmc Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
    J Fracheboud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1753, NL 3000 DR Rotterdam, The Netherlands
    Br J Cancer 91:861-7. 2004
    ..It is evident that breast cancer screening contributes to a reduction in advanced breast cancers and breast cancer mortality...
  18. pmc Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality
    M M Vervoort
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, and Netherlands Institute for Health Sciences, The Netherlands
    Br J Cancer 91:242-7. 2004
    ..In conclusion, although adjuvant systemic therapy can reduce breast cancer mortality rates, it is anticipated to be less than the mortality reduction caused by mammography screening...
  19. ncbi request reprint Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round
    M E van den Akker-van Marle
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Int J Cancer 73:464-9. 1997
    ..Interval cancer rates, results of the subsequent round and size distributions are also crucial indicators of the quality of the screening programme and should be analysed in their specific context...
  20. ncbi request reprint Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995
    P M Beemsterboer
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Eur J Cancer 35:450-4. 1999
    ..Opportunistic screening was not clearly demonstrated in adjacent age groups...
  21. ncbi request reprint First experiences in screening women at high risk for breast cancer with MR imaging
    M M Tilanus-Linthorst
    Department of Radiology, Daniel den Hoed Clinic, Erasmus University Rotterdam, The Netherlands
    Breast Cancer Res Treat 63:53-60. 2000
    ..Breast MRI is promising in screening young women at high risk for breast cancer, as it can advance the detection of cancers still occult at mammography and physical examination; but the cost may be considerable...
  22. pmc Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
    K A M van den Bergh
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands
    Br J Cancer 102:27-34. 2010
    ..In subjects with either an indeterminate or a negative result after screening, we investigated whether health-related quality of life (HRQoL) changed over time and differed between groups in the short term...
  23. pmc Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up
    I J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Br J Cancer 94:1093-8. 2006
    ..STAI-State can be a useful screening tool but needs further development...
  24. pmc Impact of screening for breast cancer in high-risk women on health-related quality of life
    A J Rijnsburger
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Br J Cancer 91:69-76. 2004
    ..In this study, high-risk women who opted for regular breast cancer screening had a better health status than women from the general population...
  25. ncbi request reprint Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch
    A J Rijnsburger
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Qual Life Res 15:933-40. 2006
    ..To assess the psychometric properties of a Dutch adaptation of an originally Australian instrument measuring the psychological impact of breast cancer screening...
  26. doi request reprint Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur J Cancer 46:3061-7. 2010
    ....
  27. doi request reprint PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur J Cancer 46:3053-60. 2010
    ..To describe the variation in PSA level by age group and screening round in the ERSPC centres and the variation in cancer detection rates in relation to the underlying prostate cancer incidence...
  28. doi request reprint The impact of a lung cancer computed tomography screening result on smoking abstinence
    C M van der Aalst
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur Respir J 37:1466-73. 2011
    ..Screening test outcomes could be used as a teachable moment for smoking cessation...
  29. pmc Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions
    F W Schultz
    Erasmus MC, Department of Public Health, Rotterdam, The Netherlands
    Risk Anal 32:S85-98. 2012
    ..The model fits in the actual tobacco-control scenario, providing credibility to the estimates of other scenarios, although considering survey-reported smoking trends alone has limitations...
  30. ncbi request reprint Detecting language problems: accuracy of five language screening instruments in preschool children
    H M E van Agt
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Dev Med Child Neurol 49:117-22; discussion 84. 2007
    ..The area under the ROC curves, ranged from 0.75 to 0.87. Apparently, short and simple parent report instruments like the LSI-PF and the one-item VAS perform remarkably well in detecting language delays in preschool children...
  31. pmc Changes in use of breast-conserving therapy in years 1978-2000
    H J de Koning
    Department of Public Health, Erasmus Universiteit, Rotterdam, The Netherlands
    Br J Cancer 70:1165-70. 1994
    ..Given the rapidity of change towards the use of breast-conserving surgery, which is enhanced by screening, recent information will be needed in predicting capacity and assessing whether screen-detected women are treated adequately...
  32. pmc Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths
    R de Gelder
    Erasmus MC, Department of Public Health, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    Br J Cancer 104:1214-20. 2011
    ..Because the radiation risk increases with lower exposure age, advancing the lower age limit may affect the balance between screening benefits and risks. The present study explores the benefit-risk ratio of screening before age 50...
  33. ncbi request reprint Mammographic screening: evidence from randomised controlled trials
    H J de Koning
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Ann Oncol 14:1185-9. 2003
    ..A summary of the prerequisites for methodological quality and its available evidence from the trials is given. Data to support breast cancer mortality as a correct outcome measure are presented...
  34. ncbi request reprint MISCAN: estimating lead-time and over-detection by simulation
    G Draisma
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    BJU Int 92:106-11. 2003
    ..To estimate the mean lead-time and rate of over-detection associated with screening for prostate cancer with prostate-specific antigen...
  35. doi request reprint Blinded and uniform cause of death verification in a lung cancer CT screening trial
    N Horeweg
    Department of Public Health, Erasmus MC Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Lung Cancer 77:522-5. 2012
    ..Our results imply that the final outcome of a lung cancer screening trial cannot reliably be established without predetermined criteria and an independent review of blinded cases...
  36. doi request reprint Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity?
    C M van der Aalst
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 24:465-78. 2010
    ..Integrated approaches to combine primary and secondary prevention have the potential to optimise the efforts to improve cancer prevention and survival. More research is warranted to investigate evidence-based approaches...
  37. pmc Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy
    J H Groenewoud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Br J Cancer 90:383-92. 2004
    ....
  38. ncbi request reprint Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    J Med Screen 11:89-92. 2004
    ..In addition, the accuracy of the randomisation was evaluated by comparison amongst the trial arms...
  39. ncbi request reprint [The scientific basis for population screening for breast cancer in the Netherlands]
    H J de Koning
    Erasmus Universiteit, Instituut Maatschappelijke Gezondheidszorg, Postbus 1738, 3000 DR Rotterdam
    Ned Tijdschr Geneeskd 146:1034-41. 2002
    ..However, the evaluation of breast-cancer mortality over the next five years is crucial, if greater certainty is to be gained about this...
  40. ncbi request reprint A cluster-randomised trial of screening for language disorders in toddlers
    H J de Koning
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    J Med Screen 11:109-16. 2004
    ..To assess the screening performance of a specific language-screening instrument at 18 and 24 months of age and to assess its effect on the early detection and prognosis of language delay...
  41. ncbi request reprint Monitoring the ERSPC trial
    H J de Koning
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 92:112-4. 2003
  42. ncbi request reprint Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram
    E W Steyerberg
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Urol 177:107-12; discussion 112. 2007
    ..Statistical models have been proposed to predict indolent cancer. We validated and updated model predictions for a screening setting...
  43. doi request reprint Informed decision-making about the fetal anomaly scan: what knowledge is relevant?
    H M H J D Schoonen
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Ultrasound Obstet Gynecol 37:649-57. 2011
    ..The second was to compare the contents of decision-relevant knowledge for second-trimester ultrasound screening with those for first-trimester screening for Down syndrome using the combined test...
  44. doi request reprint Predictors of HPV vaccination uptake: a longitudinal study among parents
    R Hofman
    Department of Public Health, Erasmus University Medical Centre, 3000 CA Rotterdam, The Netherlands, Department of Health Promotion, TNO Quality of Life, 2333 AL Leiden, the Netherlands and Municipal Public Health Service Rotterdam Rijnmond, 3011 EN Rotterdam, The Netherlands
    Health Educ Res 29:83-96. 2014
    ..Decisions regarding new vaccines are difficult to make, we recommend a well-balanced implementation process. ..
  45. ncbi request reprint Measuring disease specific quality of life in localized prostate cancer: the Dutch experience
    I J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Qual Life Res 12:459-64. 2003
    ..We aimed at developing and testing a Dutch health-related quality of life measure for localized prostate cancer patients...
  46. pmc Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening
    L E M Duijm
    Department of Radiology, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands
    Br J Cancer 91:1795-9. 2004
    ..To improve the workup, we suggest that other breast cancer screening programmes also identify delay in breast cancer diagnosis after a positive screen...
  47. ncbi request reprint Determining the cause of death in randomized screening trial(s) for prostate cancer
    H J de Koning
    Erasmus MC, Department Public Health, Rotterdam, The Netherlands
    BJU Int 92:71-8. 2003
  48. ncbi request reprint Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)
    M J Roobol
    Department of Urology, Erasmus Medical Centre Rotterdam, Netherlands Institute for Health Sciences, Rotterdam, The Netherlands
    Urology 63:309-13; discussion 313-5. 2004
    ..0 ng/mL or less. Digital rectal examination and/or transrectal ultrasonography have been used as screening tools at these low PSA levels, but this approach is not very efficient...
  49. ncbi request reprint Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland
    A R Aro
    Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
    Psychol Med 35:1515-21. 2005
    ..Belief that depression and other psychological factors predict breast cancer is common, but there have been few prospective epidemiological studies on this relationship...
  50. ncbi request reprint Lung cancer screening by low-dose spiral computed tomography
    R J van Klaveren
    Dept of Pulmonology, University Hospital Rotterdam, The Netherlands
    Eur Respir J 18:857-66. 2001
    ..It is strongly recommended that lung cancer screening be evaluated in randomized trials in order to allow evidence-based health policy decisions to be made on this subject...
  51. ncbi request reprint Diagnosing non-palpable breast disease: short-term impact on quality of life of large-core needle biopsy versus open breast biopsy
    H M Verkooijen
    Department of Surgery, University Medical Center, Utrecht, The Netherlands
    Surg Oncol 10:177-81. 2002
    ..In this prospective study, the quality of life of patients undergoing large-core needle biopsy was compared with that of patients undergoing open breast biopsy prior to learning the definitive diagnosis...
  52. ncbi request reprint Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer
    S Van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Community Genet 6:235-41. 2003
    ..Surveillance consists of biannual physical examination, annual mammography, annual MRI and monthly breast self-examination (BSE)...
  53. ncbi request reprint Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
    M Kriege
    Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Centre, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:357-63. 2007
    ....
  54. ncbi request reprint MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)
    M Kriege
    Rotterdam Family Cancer Clinic, Erasmus MC (University Medical Centre Rotterdam)/Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Fam Cancer 1:163-8. 2001
    ..The aim is to include 2,500 women. The study started on 1 November 1999. On 1 January 2002, more than 1,700 women, including 210 proven carriers of a BRCA1 or BRCA2 mutation, were included in the study...
  55. ncbi request reprint Passive coping and psychological distress in women adhering to regular breast cancer surveillance
    K Pieterse
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Psychooncology 16:851-8. 2007
    ..Coping style was not associated with the trend of psychological distress around the two surveillance appointments. It is recommendable to take coping styles into account when counselling these high-risk women...
  56. ncbi request reprint [Multi-detector CT screening for lung cancer is still to be discouraged for the time being]
    R J van Klaveren
    Erasmus MC Centrum, Rotterdam
    Ned Tijdschr Geneeskd 152:125-8. 2008
    ....
  57. ncbi request reprint Why improvement in survival of screen-detected cases is not necessarily equivalent to benefit?
    H J de Koning
    Breast 12:299-301. 2003